Alpha Cognition, Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
ACI is a privately held biopharmaceutical company headquartered in Vancouver, BC (Canada) with operations in Prince Edward Island and West Palm Beach, Florida. ACI is focused on the development of two new therapeutic products: Alpha-1062 for the treatment of mild to moderate Alzheimer’s Disease, and Alpha-602 for the treatment of amyotrophic lateral sclerosis (ALS).
Company Type:
Company Website:
Company HQ State:
British Columbia
Company HQ Country:
Canada
Year Founded:
2020
Main Therapeutic Focus:
Lead Product in Development:
Alpha-1062
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
2
Speaker
photo
President
Alpha Cognition, Inc.